Purple Biotech (NASDAQ:PPBT) reported quarterly losses of $(0.27) per share.
Magnificent 7 Or Bust? Chamath Palihapitiya Says Mega-Cap Stocks Approach ‘Heady’ Valuation — Explains Why So Much Money Sits On Sidelines
Chamath Palihapitiya warned of the Magnificent 7's valuation approaching heady levels and delved into a way to gain less-risky exposure to these stocks.